Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulcrum Therapeutics (FULC) Change in Intangibles (2019)

Fulcrum Therapeutics (FULC) has disclosed Change in Intangibles for 1 consecutive years, with $91000.0 as the latest value for Q1 2019.

  • On a quarterly basis, Change in Intangibles changed N/A to $91000.0 in Q1 2019 year-over-year; TTM through Dec 2019 was $91000.0, a N/A change, with the full-year FY2019 number at $91000.0, changed N/A from a year prior.
  • Change in Intangibles was $91000.0 for Q1 2019 at Fulcrum Therapeutics.
  • In the past five years, Change in Intangibles ranged from a high of $91000.0 in Q1 2019 to a low of $91000.0 in Q1 2019.